F. Latif

3.4k total citations · 1 hit paper
105 papers, 1.8k citations indexed

About

F. Latif is a scholar working on Surgery, Transplantation and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, F. Latif has authored 105 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Surgery, 43 papers in Transplantation and 28 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in F. Latif's work include Transplantation: Methods and Outcomes (65 papers), Renal Transplantation Outcomes and Treatments (41 papers) and Cardiac Structural Anomalies and Repair (29 papers). F. Latif is often cited by papers focused on Transplantation: Methods and Outcomes (65 papers), Renal Transplantation Outcomes and Treatments (41 papers) and Cardiac Structural Anomalies and Repair (29 papers). F. Latif collaborates with scholars based in United States, Norway and United Kingdom. F. Latif's co-authors include Mathew S. Maurer, Ted Pozniakoff, Adam Castaño, Sabahat Bokhari, P.C. Colombo, Susan Restaino, Yoshifumi Naka, Maryjane Farr, Nir Uriel and Ulrich P. Jorde and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Biophysical Journal.

In The Last Decade

F. Latif

87 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

^99m Tc-Pyrophosphate Scintigraphy for Differentiating Light-Chain Cardiac Amyloidosis From the Transthyretin-Related Familial and Senile Cardiac Amyloidoses

2013 424 citations F. Latif et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. Latif United States	19	733	625	516	427	237	105	1.8k
Jack F. Price United States	27	989 1.3×	2.1k 3.3×	446 0.9×	747 1.7×	84 0.4×	133	3.1k
J. Trent Magruder United States	24	881 1.2×	547 0.9×	76 0.1×	278 0.7×	102 0.4×	79	1.6k
Maria Frigerio Italy	25	989 1.3×	1.6k 2.5×	133 0.3×	502 1.2×	194 0.8×	107	2.3k
Luís Almenar Spain	28	1.9k 2.5×	734 1.2×	216 0.4×	633 1.5×	966 4.1×	182	2.7k
Justus Strauch Germany	20	450 0.6×	744 1.2×	89 0.2×	223 0.5×	75 0.3×	71	1.4k
D. Eric Steidley United States	14	749 1.0×	372 0.6×	76 0.1×	386 0.9×	100 0.4×	44	1.2k
Leonid Sternik Israel	22	936 1.3×	1.2k 2.0×	173 0.3×	159 0.4×	37 0.2×	104	2.0k
Eduardo Barge‐Caballero Spain	20	631 0.9×	485 0.8×	102 0.2×	322 0.8×	126 0.5×	120	1.1k
Anton Sabashnikov Germany	27	1.9k 2.6×	775 1.2×	124 0.2×	1.4k 3.3×	160 0.7×	200	2.7k
P. Kalmár Germany	22	514 0.7×	942 1.5×	487 0.9×	114 0.3×	71 0.3×	122	1.9k

Countries citing papers authored by F. Latif

Since Specialization

Citations

This map shows the geographic impact of F. Latif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Latif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Latif more than expected).

Fields of papers citing papers by F. Latif

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Latif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Latif. The network helps show where F. Latif may publish in the future.

Co-authorship network of co-authors of F. Latif

This figure shows the co-authorship network connecting the top 25 collaborators of F. Latif. A scholar is included among the top collaborators of F. Latif based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Latif. F. Latif is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Latif, F., et al.. (2025). Impact of Donor and Recipient Sex‐Mismatch in Donation After Circulatory Death Heart Transplant. Clinical Transplantation. 39(9). e70285–e70285.

Oren, Daniel, D. Bae, Dor Lotan, et al.. (2025). Extracorporeal Photopheresis in the Treatment of Cardiac Allograft Rejection in the Modern Era: A Single‐Center Experience. Clinical Transplantation. 39(8). e70247–e70247. 1 indexed citations

Abrams, Melinda K., Sanjay Salgado, J. Raikhelkar, et al.. (2025). Screening and Surveillance for Colorectal Cancer Before and After Heart Transplantation. Clinical Transplantation. 39(9). e70301–e70301.

DeFilippis, Ersilia M., G. Sayer, J. Fried, et al.. (2025). PET/CT with Myocardial Blood Flow Assessment Is Prognostic of Cardiac Allograft Vasculopathy Progression and Clinical Outcomes. Journal of Nuclear Medicine. 66(2). 264–270. 2 indexed citations

Oren, Daniel, Ersilia M. DeFilippis, Kevin J. Clerkin, et al.. (2024). Long‐term outcomes for pediatric heart transplant recipients transitioning to adult care teams. Clinical Transplantation. 38(4). e15282–e15282. 1 indexed citations

Clerkin, Kevin J., Lorenzo R. Sewanan, Jan M. Griffin, et al.. (2024). Added prognostic value of visually estimated coronary artery calcium among heart transplant recipients. The Journal of Heart and Lung Transplantation. 43(11). 1795–1805. 2 indexed citations

Driggin, Elissa, Jaya Batra, Fabian Vargas, et al.. (2024). Cardio‐Renal‐Metabolic Outcomes Associated With the Use of GLP‐1 Receptor Agonists After Heart Transplantation. Clinical Transplantation. 38(7). e15401–e15401. 1 indexed citations

Kurlansky, Paul, et al.. (2024). Bridge to simultaneous heart-kidney transplantation via extracorporeal life support: National outcomes in the new heart allocation policy era. The Journal of Heart and Lung Transplantation. 44(1). 11–21.

Driggin, Elissa, J. Fried, J. Raikhelkar, et al.. (2024). Cardiometabolic Outcomes Associated with the use of Semaglutide After Heart Transplantation. The Journal of Heart and Lung Transplantation. 43(4). S223–S223.

10.

Lotan, Dor, D. Bae, Ersilia M. DeFilippis, et al.. (2023). The utilization of molecular microscope in management of heart transplant recipients in the era of noninvasive monitoring. Clinical Transplantation. 37(12). e15131–e15131. 2 indexed citations

11.

Oren, Daniel, Jennifer Haythe, Dor Lotan, et al.. (2023). Pumping for Two: Pregnancy in Patients Supported With a Left Ventricular Assist Device. ASAIO Journal. 70(6). 461–468. 1 indexed citations

12.

Lotan, Dor, Ersilia M. DeFilippis, Daniel Oren, et al.. (2023). Combined heart and liver transplantation in a patient supported by left ventricular assist device (LVAD) with propionic acidemia. Nutrition Metabolism and Cardiovascular Diseases. 33(3). 667–670. 2 indexed citations

13.

Raikhelkar, J., Luke Benvenuto, Veli K. Topkara, et al.. (2023). Impact of preheart transplant spirometry and DLCO measurement on post-transplant pulmonary outcomes. The Journal of Heart and Lung Transplantation. 42(6). 819–827.

14.

Topkara, Veli K., Kevin J. Clerkin, J. Fried, et al.. (2021). Exception Status Listing in the New Adult Heart Allocation System: A New Solution to an Old Problem?. Circulation Heart Failure. 14(6). e007916–e007916. 21 indexed citations

15.

Diakos, Nikolaos, Susan Restaino, Kevin J. Clerkin, et al.. (2021). A Rare Case of Disseminated Tuberculosis and Hematological Malignancy in a Heart Transplant Recipient. Transplantation Proceedings. 53(8). 2626–2629. 1 indexed citations

16.

Shimada, Yuichi J., et al.. (2019). Myocardial Contraction Fraction Predicts Cardiovascular Events in Patients With Hypertrophic Cardiomyopathy and Normal Ejection Fraction. Journal of Cardiac Failure. 25(6). 450–456. 17 indexed citations

17.

Lange, Nicholas W., William L. Baker, M. Shullo, et al.. (2018). Outcomes Associated With Mammalian Target of Rapamycin (mTOR) Inhibitors in Heart Transplant Recipients: A Meta-analysis. The Journal of Heart and Lung Transplantation. 37(4). S90–S91. 1 indexed citations

18.

Latif, F., et al.. (2014). Ear pain, vesicular rash, and facial palsy. BMJ. 349(dec10 17). g7572–g7572. 1 indexed citations

19.

Maurer, Matthew J., et al.. (2011). CHANGES IN THE TYPE OF CARDIAC AMYLOIDOSIS DIAGNOSED AT A TERTIARY REFERRAL CENTER: ONE IMPACT OF AN AGING POPULATION. Journal of the American College of Cardiology. 57(14). E247–E247. 1 indexed citations

20.

Pak, Sang‐Woo, Nir Uriel, Elizabeth Burke, et al.. (2010). Abstract 20395: High Incidence of Elevated Panel Reactive Antibodies in Patients Supported with HeartMate II Left Ventricular Assist Devices. Circulation. 122. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact